Lucile Blaise - 15 Nov 2022 Form 4/A - Amendment Insider Report for RESMED INC (RMD)

Role
President, Sleep & RC Business
Signature
Lucile Blaise, President, Sleep & Respiratory Care
Issuer symbol
RMD
Transactions as of
15 Nov 2022
Net transactions value
+$503,182
Form type
4/A - Amendment
Filing time
18 Nov 2022, 18:18:37 UTC
Date Of Original Report
16 Nov 2022
Previous filing
15 Jul 2022
Next filing
22 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Tax liability $38,055 -169 -2.4% $225.18 6,819 15 Nov 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMD ResMed Common Stock Options Award $541,238 +2,410 $224.58 2,410 16 Nov 2022 ResMed Common Stock 2,410 $224.58 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Corrects transaction as disposition to issuer for tax withholding on scheduled vesting of Restricted Stock Units granted 11/14/2018.
F2 Reflects corrected share beneficially owned.
F3 Represents date options first become exercisable. Options vest 1/3 annually each November 11, 2023, 2024 and 2025.